Stocks
Heron Therapeutics (HRTX) R&D/CAPEX US GAAP (year values) |
|||||||||
| 2019 | 2020 | 2021 | 2022 | 2023 | LTM ? | CAGR 5 years ? | |||
| R&D/CAPEX, % | 2 340% | 2 562% | 4 329% | 5 891% | 3 618% | 3 534% | |||
| Changes by years, y/y, % | +813pp | +222pp | +1 767pp | +1 562pp | -2 273pp | +18.8% | |||
Heron Therapeutics. R&D/CAPEX, %
Heron Therapeutics. R&D/CAPEX, changes, pp
Heron Therapeutics (HRTX) R&D/CAPEX US GAAP (quarter values) |
||||||||
| 2022Q4 | 2023Q1 | 2023Q2 | 2023Q3 | 2023Q4 | LTM ? | |||
| R&D/CAPEX, % | 2 671% | 6 168% | 6 321% | 1 710% | 4 380% | 3 534% | ||
| Changes by years, y/y, % | -4 734pp | +2 139pp | -2 634pp | -55 057pp | +1 709pp | |||
| Changes by quarters, q/q, % | -54 096pp | +3 498pp | +153pp | -4 611pp | +2 670pp | |||
